LH insider transactions
Labcorp Holdings Inc. (LH) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
LH insiders
Everyone who has filed a Form 3, 4, 5 or 144 at Labcorp Holdings Inc., latest first. Follow anyone to get their next filing.
- Bryan T VaughnEVP and President, Diagnostics, since January 2026-$175K
- Richelle P ParhamDirector-$2.17M
- Akinbolade OyegunwaEVP, CIO & CTO, since November 2024
- Jonathan C MeltzerEVP, COO, since January 2026-$299K
- Brian J CaveneyEVP, Pres of BLS, CMO & CSO+$20.4K-$923K
- Kerrii B AndersonDirector-$5.15M
- Adam H SchechterPresident & CEO, Director-$14.5M
- Amy B. SummyEVP, Chief Marketing Officer-$2.27M
- Peter J WilkinsonSVP, Chief Accounting Officer-$3.68M
- Kathryn W KyleEVP, Chief Legal Officer, since January 2026-$227K
- Sandra D van der VaartEVP, Corporate Affairs-$7.39M
- Anita Z GrahamEVP, Chro, since April 2023
- Mark S SchroederEVP, Pres Diagnostics & COO-$7.24M
- Megan D. BaileyEVP, Pres, Central Labs & Intl, since May 2023
- Julia Aijun WangChief Financial Officer, EVP, since December 2024
- Paul RothmanDirector, since June 2023
- Kathryn E WengelDirector, since March 2021
- Peter M NeupertDirector+$923K
- Garheng KongDirector
- Kirsten Marie KliphouseDirector, since October 2022
- Jeffrey A. DavisDirector
- John H SampsonDirector, since February 2026
- Carulla Victor BultoDirector
- Dwight Gary GillilandDirector-$922K
- Glenn A EisenbergExecutive Vice President-$27M
- Lance BerberianEVP, Special Advisor, Strategy-$2.77M
- Jonathan P. DiVincenzoEVP, Pres, Central Labs & Intl, since May 2023-$108K
- R Sanders WilliamsDirector-$156K
- Jean-Luc BelingardDirector-$700K
- Paul R KirchgraberOfficer-$3.63M
- Judith C SeltzOfficer
- Thomas PikeOfficer, since January 2023
Recent Form 3, 4, and 5 filings for LH
- EVP and President, Diagnostics Vaughn Bryan T sold $108,232 worth of shares (306 units at $353.70) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 6,845 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- Director Parham Richelle P sold $389,395 worth of shares (1,078 units at $361.22), decreasing direct ownership by 32% to 2,288 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- EVP, CIO & CTO Oyegunwa Akinbolade converted options into 370 shares and covered exercise/tax liability with 118 shares, increasing direct ownership by 5% to 5,316 units (SEC Form 4) to satisfy tax liability4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- EVP and President, Diagnostics Vaughn Bryan T converted options into 500 shares and covered exercise/tax liability with 194 shares, increasing direct ownership by 4% to 7,151 units (SEC Form 4) to cover taxes4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by EVP, CIO & CTO Oyegunwa Akinbolade4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by EVP, COO Meltzer Jonathan C4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by EVP and President, Diagnostics Vaughn Bryan T4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by EVP, Pres of BLS, CMO & CSO Caveney Brian J4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- Director Anderson Kerrii B sold $954,060 worth of shares (3,000 units at $318.02) as part of a pre-agreed trading plan, decreasing direct ownership by 31% to 6,563 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- President & CEO Schechter Adam H sold $1,495,808 worth of shares (4,669 units at $320.37) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 102,565 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- EVP, Chief Marketing Officer Summy Amy B. sold $283,428 worth of shares (924 units at $306.74), decreasing direct ownership by 12% to 6,956 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SVP, Chief Accounting Officer Wilkinson Peter J sold $439,107 worth of shares (1,420 units at $309.23) and exercised 1,338 shares at a strike of $209.25, decreasing direct ownership by 4% to 1,770 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- EVP, Chief Legal Officer Kyle Kathryn W converted options into 256 shares, covered exercise/tax liability with 73 shares and sold $26,329 worth of shares (92 units at $286.19) as part of a pre-agreed trading plan, increasing direct ownership by 2% to 3,904 units (SEC Form 4) (for withholding tax)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- EVP and President, Diagnostics Vaughn Bryan T covered exercise/tax liability with 93 shares, sold $66,968 worth of shares (234 units at $286.19) as part of a pre-agreed trading plan and converted options into 327 shares (SEC Form 4) (for withholding tax)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- EVP, Chief Legal Officer Kyle Kathryn W sold $201,084 worth of shares (762 units at $263.89) as part of a pre-agreed trading plan, decreasing direct ownership by 17% to 3,813 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- President & CEO Schechter Adam H sold $1,502,314 worth of shares (5,903 units at $254.50) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 107,234 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Schechter Adam H4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Graham Anita Z4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Schroeder Mark S4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Caveney Brian J4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Wilkinson Peter J4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Vaughn Bryan T4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Van Der Vaart Sandra D4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Summy Amy B.4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Oyegunwa Akinbolade4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Meltzer Jonathan C4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Kyle Kathryn W4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Bailey Megan D.4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- President & CEO Schechter Adam H sold $2,437,047 worth of shares (8,705 units at $279.96), decreasing direct ownership by 10% to 80,773 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- EVP, Corporate Affairs Van Der Vaart Sandra D sold $156,000 worth of shares (548 units at $284.91), decreasing direct ownership by 18% to 2,579 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- EVP, Pres of ED, CMO & CSO Caveney Brian J sold $429,458 worth of shares (1,500 units at $286.31), decreasing direct ownership by 5% to 30,107 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SVP, Chief Accounting Officer Wilkinson Peter J sold $185,108 worth of shares (666 units at $277.94), decreasing direct ownership by 26% to 1,852 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- EVP, Chief Marketing Officer Summy Amy B. converted options into 230 shares and covered exercise/tax liability with 83 shares, increasing direct ownership by 3% to 5,722 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SVP, Chief Accounting Officer Wilkinson Peter J converted options into 696 shares and covered exercise/tax liability with 206 shares, increasing direct ownership by 24% to 2,518 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- Chief Financial Officer, EVP Wang Julia Aijun covered exercise/tax liability with 245 shares and converted options into 860 shares, increasing direct ownership by 51% to 1,817 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- EVP, Diagnostics Vaughn Bryan T converted options into 323 shares and covered exercise/tax liability with 93 shares, increasing direct ownership by 4% to 5,613 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- EVP, Corporate Affairs Van Der Vaart Sandra D converted options into 376 shares and covered exercise/tax liability with 99 shares, increasing direct ownership by 10% to 3,126 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- EVP, Pres Diagnostics & COO Schroeder Mark S converted options into 806 shares and covered exercise/tax liability with 259 shares, increasing direct ownership by 9% to 6,473 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- President & CEO Schechter Adam H sold $1,499,536 worth of shares (5,273 units at $284.38), converted options into 3,656 shares and covered exercise/tax liability with 1,521 shares, decreasing direct ownership by 3% to 89,478 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- EVP, CIO & CTO Oyegunwa Akinbolade converted options into 230 shares and covered exercise/tax liability with 68 shares, increasing direct ownership by 4% to 4,106 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- EVP, Operations Meltzer Jonathan C converted options into 243 shares, covered exercise/tax liability with 70 shares and sold $25,267 worth of shares (87 units at $290.42), increasing direct ownership by 3% to 2,782 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- EVP, Chief Legal Officer Kyle Kathryn W converted options into 216 shares and covered exercise/tax liability with 62 shares, increasing direct ownership by 5% to 3,442 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- EVP, CHRO Graham Anita Z converted options into 356 shares and covered exercise/tax liability with 109 shares, increasing direct ownership by 20% to 1,460 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- EVP, Pres of ED, CMO & CSO Caveney Brian J covered exercise/tax liability with 211 shares and converted options into 740 shares, increasing direct ownership by 2% to 31,607 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- EVP, Pres, Central Labs & Intl Bailey Megan D. converted options into 403 shares and covered exercise/tax liability with 138 shares, increasing direct ownership by 7% to 4,148 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- Director Rothman Paul converted options into 897 shares, increasing direct ownership by 54% to 2,571 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- Director Wengel Kathryn E converted options into 897 shares, increasing direct ownership by 28% to 4,133 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- Director Parham Richelle P converted options into 897 shares, increasing direct ownership by 36% to 3,366 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- Director Neupert Peter M converted options into 897 shares, increasing direct ownership by 7% to 13,784 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- Director Kong Garheng converted options into 897 shares, increasing direct ownership by 7% to 13,739 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- Director Kliphouse Kirsten Marie converted options into 897 shares, increasing direct ownership by 40% to 3,160 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- Director Davis Jeffrey A. converted options into 897 shares, increasing direct ownership by 20% to 5,460 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- Director Anderson Kerrii B converted options into 897 shares, increasing direct ownership by 10% to 9,563 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by President & CEO Schechter Adam H4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- EVP, Operations Meltzer Jonathan C sold $25,188 worth of shares (91 units at $276.79), decreasing direct ownership by 3% to 2,696 units (SEC Form 4)4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by EVP, Chief Legal Officer Kyle Kathryn W4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by EVP, Diagnostics Vaughn Bryan T4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by Chief Financial Officer, EVP Wang Julia Aijun4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by SVP, Chief Accounting Officer Wilkinson Peter J4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)
- SEC Form 4 filed by EVP, CIO & CTO Oyegunwa Akinbolade4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)